Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
30.66
-0.86 (-2.73%)
At close: Jun 20, 2025, 4:00 PM
30.99
+0.33 (1.08%)
After-hours: Jun 20, 2025, 7:39 PM EDT
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$557,220
Profits / Employee
-$56,796
Market Cap
1.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HROW News
- 2 days ago - Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications - Business Wire
- 7 days ago - I Am Swimming In Dividends With +7% Yields - Seeking Alpha
- 11 days ago - Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals - Business Wire
- 23 days ago - Harrow: Epic Growth & Operating Leverage On Full Display - Seeking Alpha
- 5 weeks ago - Harrow to Present at Two Investor Conferences in May - Business Wire
- 5 weeks ago - Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Harrow Announces First-Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 - Business Wire